FDA Inspection 1100650 — Northern Illinois Blood Bank

Northern Illinois Blood Bank — FEI 3006104544

The FDA completed an inspection of Northern Illinois Blood Bank on August 6, 2019 in Freeport, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 6, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Freeport, IL (United States)